Skip to content

GeneDx Holdings WGS Earnings yield

Earnings yield at other companies

Natera, Inc. logo
Natera, Inc.NTRA
-1.4%0.0pp
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
-3.7%-1.3pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
2.2%+1.2pp
Quest Diagnostics logo
Quest DiagnosticsDGX
4.8%0.0pp
Revvity logo
RevvityRVTY
2.4%+0.2pp
Labcorp Holdings logo
Labcorp HoldingsLH
4.3%+0.5pp

Other financials

Income statement

See full
Revenue$102.3M+17.4%
Gross profit$68.2M+16.6%
Operating income-$57.5M-1,163%
Net income-$63.3M-870%
EPS (diluted)-$2.16-839%

Balance sheet

See full
Cash & equivalents$94.9M-5.7%
Total debt$96.7M+82.5%
Total equity$254.1M-1.3%
Total assets$506.3M+13.4%

Cash flow

See full
Operating cash flow-$32.4M-418%
CapEx$6.5M+5.3%
Free cash flow-$38.9M-1,059%

Valuation

See full
Market cap$1.72B-24.3%
Enterprise value$1.73B-22.8%
P/S3.9×-3.0×

Profitability

See full
Gross margin69.6%+4.3pp
Operating margin-14.9%
Net margin-17.6%
FCF margin3.8%+2.1pp

Returns & leverage

See full
Return on equity-30.4%
Debt / equity0.4×+0.2×
Current ratio3.1×-0.2×

Where this comes from

Calculated from GeneDx Holdings’s reported figures.

Based on trailing twelve months.

The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about GeneDx Holdings's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GeneDx Holdings's earnings yield?
GeneDx Holdings (WGS) reported earnings yield of -4.1% in Q1 2026.
What is the long-term trend for GeneDx Holdings's earnings yield?
Over 3 years (2021 to 2025), GeneDx Holdings's earnings yield has grown at a -6.8% compound annual growth rate (CAGR), from -0.7% to -0.6%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.